Erratum for Velásquez et al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis
Antimicrob Agents Chemother
.
2017 Feb 23;61(3):e00069-17.
doi: 10.1128/AAC.00069-17.
Print 2017 Mar.
Authors
Gustavo E Velásquez
1
2
3
,
Roger I Calderon
4
,
Carole D Mitnick
4
5
6
,
Mercedes C Becerra
4
5
6
,
Chuan-Chin Huang
7
,
Zibiao Zhang
6
,
Carmen C Contreras
4
,
Rosa M Yataco
4
,
Jerome T Galea
4
,
Leonid W Lecca
4
,
Megan B Murray
4
5
6
8
Affiliations
1
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
2
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
3
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
4
Partners In Health/Socios En Salud, Boston, Massachusetts, USA, and Lima, Peru.
5
Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
6
Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
7
Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
8
Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
PMID:
28232308
PMCID:
PMC5328511
DOI:
10.1128/AAC.00069-17
No abstract available
Publication types
Published Erratum
Grants and funding
U19 AI076217/AI/NIAID NIH HHS/United States
U19 AI109755/AI/NIAID NIH HHS/United States
U01 AI057786/AI/NIAID NIH HHS/United States
L30 AI120170/AI/NIAID NIH HHS/United States
T32 AI007433/AI/NIAID NIH HHS/United States